Clinical Trial Update: Fasudil fOr redUcing elopemeNt and Spatial Disorientation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial on Fasudil for reducing elopement and spatial disorientation in dementia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia

Drugs mentioned

• fasudil (fasudil)

Snippet

Sponsor: Woolsey Pharmaceuticals | Conditions: Dementia | Phase 2 | Status: COMPLETED